1. Home
  2. TLS vs RCKT Comparison

TLS vs RCKT Comparison

Compare TLS & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telos Corporation

TLS

Telos Corporation

HOLD

Current Price

$4.01

Market Cap

317.1M

Sector

Technology

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$4.45

Market Cap

534.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLS
RCKT
Founded
1969
1999
Country
United States
United States
Employees
N/A
202
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
317.1M
534.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
TLS
RCKT
Price
$4.01
$4.45
Analyst Decision
Buy
Buy
Analyst Count
5
14
Target Price
$7.90
$29.65
AVG Volume (30 Days)
892.8K
2.7M
Earning Date
03-16-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
31.51
N/A
EPS
N/A
N/A
Revenue
$164,805,000.00
N/A
Revenue This Year
$19.69
N/A
Revenue Next Year
$19.33
$97.68
P/E Ratio
N/A
N/A
Revenue Growth
52.21
N/A
52 Week Low
$1.83
$2.19
52 Week High
$8.36
$8.80

Technical Indicators

Market Signals
Indicator
TLS
RCKT
Relative Strength Index (RSI) 40.22 50.69
Support Level $3.82 $2.99
Resistance Level $5.95 $5.39
Average True Range (ATR) 0.34 0.38
MACD 0.02 -0.06
Stochastic Oscillator 14.69 22.09

Price Performance

Historical Comparison
TLS
RCKT

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: